Calorie Counting for Patients with Started GLP-1 Therapy Recently
If you have recently started taking glucagon-like peptide-1 (GLP-1) therapy for weight loss, you are likely aware of the medication's potential to help control your appetite and promote weight loss. However, combining GLP-1 therapy with a mindful, balanced diet is crucial to enhance its effectiveness and minimize potential side effects. In this article, we will explore the importance of calorie counting for patients with started GLP-1 therapy recently.
The Role of GLP-1 Therapy in Weight Loss
GLP-1 receptor agonists, such as Zepbound (retatrutide), semaglutide (Ozempic, Wegovy), and liraglutide (Saxenda), are designed to help regulate blood sugar levels, promote weight loss, and reduce appetite. These medications work by delaying gastric emptying, which helps to increase feelings of fullness and reduce hunger.
Why Calorie Counting is Essential for GLP-1 Therapy
- GLP-1 therapy can lead to a significant reduction in daily caloric intake. In some cases, patients may experience a drop in daily caloric intake from 2000-2500 calories to just 1200-1500 calories, which can lead to nutrient deficiencies if not addressed.
- Calorie counting helps ensure that patients get the nutrients they need to maintain good health, including protein, healthy fats, and complex carbohydrates.
- By tracking their calorie intake, patients can identify patterns and habits that may be contributing to their weight loss or gain, and make informed decisions to adjust their diet accordingly.
- Calorie counting can also help patients understand the relationship between food and their overall health, which is essential for maintaining long-term weight loss and overall well-being.
